Ionis Pharmaceuticals reported earnings of -$ 0.66 per IONS share on Nov 9, 2026, falling short of analysts' expectations by
| Report Date | Nov 9, 2026 |
|---|---|
| Forecasted EPS | -$ 1.23 |
| Earnings Per Share (Surprise) | -$ 0.66 (+$ 0.57) |
| Last Year's EPS | -$ 0.48 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, Ionis Pharmaceuticals beat analysts’ expectations 54 times and fell short of expectations 39 time(s). Ionis Pharmaceuticals reported earnings per share of -$ 0.66 in the last report surpassing an estimated EPS of -$ 1.23 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 1.23 | -$ 0.66 | -$ 0.61 | |
| Jul 29, 2026 | -$ 1.09 | -$ 0.69 | $ 0.86 | |
| Apr 29, 2026 | -$ 0.85 | -$ 0.56 | -$ 0.75 | |
| Feb 25, 2026 | -$ 1.24 | -$ 1.41 | -$ 0.66 | |
| Oct 29, 2025 | -$ 1.15 | -$ 0.61 | -$ 0.95 | |
| Jul 30, 2025 | $ 0.27 | $ 0.86 | -$ 0.45 | |
| Apr 30, 2025 | -$ 1.11 | -$ 0.75 | -$ 0.98 | |
| Feb 19, 2025 | -$ 1.09 | -$ 0.66 | -$ 0.06 | |
| Nov 6, 2024 | -$ 1.16 | -$ 0.95 | -$ 1.03 | |
| Aug 1, 2024 | -$ 0.92 | -$ 0.45 | -$ 0.60 | |
| May 7, 2024 | -$ 1.05 | -$ 0.98 | -$ 0.87 | |
| Feb 21, 2024 | -$ 0.83 | -$ 0.06 | -$ 0.37 | |
| Nov 2, 2023 | -$ 1.04 | -$ 1.03 | -$ 0.33 | |
| Aug 9, 2023 | -$ 0.90 | -$ 0.60 | -$ 0.74 | |
| May 3, 2023 | -$ 0.91 | -$ 0.87 | -$ 0.46 | |
| Feb 22, 2023 | -$ 1.06 | -$ 0.37 | $ 1.41 | |
| Nov 9, 2022 | -$ 0.74 | -$ 0.33 | -$ 0.58 | |
| Aug 9, 2022 | -$ 0.62 | -$ 0.74 | -$ 0.57 | |
| May 4, 2022 | -$ 0.71 | -$ 0.46 | -$ 0.64 | |
| Feb 24, 2022 | $ 0.28 | $ 1.41 | -$ 2.44 |
Ionis Pharmaceuticals’s stock was trading at $ 39.42 on Nov 8, 2026 a day before the last earnings report was released.Following the release of the earnings report, IONS’s price decreased to $ 28.19 on Nov 10, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 0.66 | $ 39.42 | $ 28.19 | |
| Jul 29, 2026 | -$ 0.69 | $ 55.30 | $ 53.28 | |
| Apr 29, 2026 | -$ 0.56 | $ 71.78 | $ 74.76 | |
| Feb 25, 2026 | -$ 1.41 | $ 85.45 | $ 80.60 | |
| Oct 29, 2025 | -$ 0.61 | $ 73.57 | $ 74.17 | |
| Jul 30, 2025 | $ 0.86 | $ 41.48 | $ 42.98 | |
| Apr 30, 2025 | -$ 0.75 | $ 29.81 | $ 31.71 | |
| Feb 19, 2025 | -$ 0.66 | $ 31.95 | $ 32.69 | |
| Nov 6, 2024 | -$ 0.95 | $ 38.80 | $ 38.46 | |
| Aug 1, 2024 | -$ 0.45 | $ 49.46 | $ 49.13 | |
| May 7, 2024 | -$ 0.98 | $ 42.28 | $ 40.16 | |
| Feb 21, 2024 | -$ 0.06 | $ 44.35 | $ 43.98 | |
| Nov 2, 2023 | -$ 1.03 | $ 45.26 | $ 47.19 | |
| Aug 9, 2023 | -$ 0.60 | $ 39.55 | $ 39.82 | |
| May 3, 2023 | -$ 0.87 | $ 35.52 | $ 35.98 | |
| Feb 22, 2023 | -$ 0.37 | $ 38.23 | $ 36.69 | |
| Nov 9, 2022 | -$ 0.33 | $ 42.25 | $ 45.47 | |
| Aug 9, 2022 | -$ 0.74 | $ 45.71 | $ 46.11 | |
| May 4, 2022 | -$ 0.46 | $ 38.50 | $ 38.05 | |
| Feb 24, 2022 | $ 1.41 | $ 30.73 | $ 31.78 |
Ionis Pharmaceuticals released its most recent earnings reports in November 2026, July 2026, April 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Ionis Pharmaceuticals beat analysts’ expectations during the last earnings period by
